Population physiologically based pharmacokińetic modeling for the human lactational transfer of PCB-153 with consideration of worldwide human biomonitoring results

Environmental Health Perspectives

Volumn 116, Issue 12, 2008, Pages 1629-1634

  Redding, Laurel E ^a,f   Sohn, Michael D ^b   McKone, Thomas E ^b,c   Chen, Jein Wen ^a   Wang, Shu Li ^a,d   Hsieh, Dennis P H ^a   Yang, Raymond S H ^a,e  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e Department of Ecosystem Science and Sustainability   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Body burden; Esposure reconstruction; Human milk biomonitoring; Lactational transfer; PCB 153Physiologically based pharmacokinetic modeling; Polychlorinated biphenyls; Reverse dosimetry

Indexed keywords

LIPID; POLYCHLORINATED BIPHENYL 153; POLYCHLORINATED BIPHENYL DERIVATIVE; UNCLASSIFIED DRUG; 2,2',4,4',5,5' HEXACHLOROBIPHENYL; 2,4,5,2',4',5'-HEXACHLOROBIPHENYL; POLYCHLORINATED BIPHENYL;

ADULT; ARTICLE; BIOLOGICAL MONITORING; BLOOD LEVEL; BREAST MILK; CHEMICAL STRUCTURE; COHORT ANALYSIS; CONTAMINATION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; JAPAN; LACTATION; PRIORITY JOURNAL; SIMULATION; TAIWAN; BIOLOGICAL MODEL; BLOOD; CHEMISTRY; ENVIRONMENTAL MONITORING; HEALTH SURVEY; METHODOLOGY;

ENVIRONMENTAL MONITORING; HUMANS; LACTATION; MILK, HUMAN; MODELS, BIOLOGICAL; POLYCHLORINATED BIPHENYLS; POPULATION SURVEILLANCE;

EID: 58149356242     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.11519     Document Type: Article

References (47)

1. Abraham K, Papke O, Gross A, Kordonouri O, Wiegand S, Wahn U, et al. (1998). Time course of PCDD/PCDF/PCB concentrations in breast-feeding mothers and their infants. Chemosphere 37:1731-1741.
2. Akutsu K, Kuwabara K, Konishi Y, Matsumoto H, Murakami Y, Tanaka Y, et al. 2005. Congener-specific analysis of PCBs in food samples by using GC/ MS [in Japanese]. Shokuhin Eiseigaku Zasshi 46:99-108.
3. Allen BC, Hack CE, Clewell HJ. 2007. Use of Markov Chain Monte Carlo analysis with a physiologically-based pharmacokinetic model of methylmercury to estimate exposures in US women of childbearing age. Risk Anal 27:947-959.
4. Angulo R, Martinez P, Jodral ML. 1999. PCB congeners transferred by human milk, with an estimate of their daily intake. Food Chem Toxicol 37:1081-1088.
5. Brambilla G, Fochi I, Falce M, De Filippis SP, Ubaldi A, di Domenico A. 2008. PCDD and PCDF depletion in milk from dairy cows according to the herd metabolic scenario. Chemosphere 73(1 suppl):S216-S219.
6. Butte NF, Garza C, Stuff JE, Smith EO, Nichols BL. 1984. Effect of maternal diet and body composition on lactational performance. Am J Clin Nutr 39:296-306.
7. Byczkowski JZ, Fisher JW. 1995. A computer program linking physiologically based pharmacokinetic model with cancer risk assessment for breast-fed infants. Comput Methods Programs Biomed 46:155-163.
8. CDC. 2005. Third National Report on Human Exposure to Environmental Chemicals. Atlanta, GA:Centers for Disease Control and Prevention.
9. Clewell RA, Gearhart JM. 2002. Pharmacokinetics of toxic chemicals in breast milk: use of PBPK models to predict infant exposure. Environ Health Perspect 110:A333-A337.
10. Covaci A, de Boer J, Ryan JJ, Voorspoels S, Schepens P. 2002. Distribution of organobrominated and organochlorinated contaminants in Belgian human adipose tissue. Environ Res 88(3):210-218.
11. De Amici D, Gasparoni A, Guala A, Klersy C. 2001. Does ethnicity predict lactation? A study of four ethnic communities. Eur J Epidemiol 17:357-362.
12. DeJongh J, Verhaar H JM, Hermens JLM. 1997. A quantitative property-property relationship (QPPR) approach to estimate in vitro tissue-blood partition coefficients of organic chemicals in rats and humans. Arch Toxicol 72:17-25.
13. Del Prado M, Villalpando S, Gordillo J, Hernandez-Montes H. 1999. A high dietary lipid intake during pregnancy and lactation enhances mammary gland lipid uptake and lipoprotein lipase activity in rats. J Nutr 129:1574-1578.
14. Dewailly É, Ayotte P, Laliberte C, Weber JP, Gingras S, Nantel AJ. 1996. Polychlorinated biphenyl (PCB) and dichlorodiphenyl dichloroethylene (DDE) concentrations in the breast milk of women in Quebec. Am J Public Health 86:1241-1246.
15. Dewailly É, Ryan JJ, Laliberté C, Bruneau S, Weber JP, Gingras S, et al. 1994. Exposure of remote maritime populations to coplanar PCBs. Environ Health Perspect 102(suppl 1):205-209.
16. Fisher J, Mahle D, Bankston L, Greene R, Gearhart J. 1997. Lactational transfer of volatile chemicals in breast milk. Am Ind Hyg Assoc J 58:425-431.
17. Gentry PR, Covington TR, Clewell HJ III. 2003. Evaluation of the potential impact of pharmacokinetic differences on tissue dosimetry in offspring during pregnancy and lactation. Regul Toxicol Pharmacol 38:1-16.
18. Glynn AW, Atuma S, Aune M, Darnerud PO, Cnattingius S. 2001. Polychlorinated biphenyl congeners as markers of toxic equivalents of polychlorinated biphenyls, dibenzo-p-dioxins and dibenzofurans in breast milk. Environ Res 86:217-228.
19. Goldey ES, Kehn LS, Lau C, Rehnberg GL, Crofton KM. 1995. Developmental exposure to polychlorinated biphenyls (Aroclor 1254) reduces circulating thyroid hormone concentrations and causes hearing deficits in rats. Toxicol Appl Pharmacol 135:77-88.
20. Greizerstein HB, Stinson C, Mendola P, Buck GM, Kostyniak PJ, Vena JE. 1999. Comparison of PCB congeners and pesticide levels between serum and milk from lactating women. Environ Res 80:280-286.
21. Haddad S, Restieri C, Krishnan K. 2001. Characterization of age-related changes in body weight and organ weights from birth to adolescence in humans. J Toxicol Environ Health A 64:453-464.
22. Haiek LN, Kramer MS, Ciampi A, Tirado R. 2001. Postpartum weight loss and infant feeding. J Am Board Fam Pract 14:85-94.
23. Huisman M, Koopman-Esseboom C, Fidler V, Hadders-Algra M, van der Paauw CG, Tuinstra LG, et al. 1995. Perinatal exposure to polychlorinated biphenyls and dioxins and its effect on neonatal neurological development. Early Hum Dev 41:111-127.
24. Inoue K, Harada K, Takenaka K, Uehara S, Kono M, Shimizu T, et al. 2006. Levels and concentration ratios of polychlorinated biphenyls and polybrominated diphenyl ethers in serum and breast milk in Japanese mothers. Environ Health Perspect 114:1179-1185.
25. Jacobson JL, Jacobson SW, Humphrey HE. 1990. Effects of in utero exposure to polychlorinated biphenyls and related contaminants on cognitive functioning in young children. J Pediatr 116:38-45.
26. Jaraczewska K, Lulek J, Covaci A, Voorspoels S, Kaluba-Skotarczak A, Drews K, et al. 2006. Distribution of polychlorinated biphenyls, organochlorine pesticides and polybrominated diphenyl ethers in human umbilical cord serum, maternal serum and milk from Wielkopolska region, Poland. Sci Total Environ 372(1):20-31.
27. Kent JC, Mitoulas LR, Cox DB, Owens RA, Hartmann PE. 1999. Breast volume and milk production during extended lactation in women. Exp Physiol 84:435-447.
28. Kent JC, Mitoulas LR, Cregan MD, Ramsay DT, Doherty DA, Hartmann PE. 2006. Volume and frequency of breastfeedings and fat content of breast milk throughout the day. Pediatrics 117:387-395.
29. Kiviranta H, Tuomisto JT, Tuomisto J, Tukiainen E, Vartiainen T. 2005. Polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls in the general population in Finland. Chemosphere 60:854-869.
30. Lee SK, Ou YC, Andersen ME, Yang RS. 2007. A physiologically based pharmacokinetic model for lactational transfer of PCB 153 with or without PCB 126 in mice. Arch Toxicol 81:101-111.
31. Minh TB, Watanabe M, Kajiwara N, Iwata H, Takahashi S, Subramanian A, et al. 2006. Human blood monitoring program in Japan: contamination and bioaccumulation of persistent organochlorines in Japanese residents. Arch Environ Contam Toxicol 51(2):296-313.
32. Mitoulas LR, Kent JC, Cox DB, Owens RA, Sherriff JL, Hartmann PE. 2002. Variation in fat, lactose and protein in human milk over 24 h and throughout the first year of lactation. Br J Nutr 88:29-37.
33. Parham FM, Kohn MC, Matthews HB, DeRosa C, Portier CJ. 1997. Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls: I. Tissue:blood partition coefficients. Toxicol Appl Pharmacol 144:340-347.
34. Patterson DG Jr, Todd GD, Turner WE, Maggio V, Alexander LR, Needham LL. 1994. Levels of non-ortho-substituted (coplanar), mono- and di- ortho-substituted polychlorinated biphenyls, dibenzo-p-dioxins, and dibenzofurans in human serum and adipose tissue. Environ Health Perspect 102(suppl 1):195-204.
35. Polder A, Odland JO, Tkachev A, Foreid S, Savinova TN, Skaare JU. 2003. Geographic variation of chlorinated pesticides, toxaphenes and PCBs in human milk from sub-arctic and arctic locations in Russia. Sci Total Environ 306:179-195.
36. Price PS, Conolly RB, Chaisson CF, Gross EA, Young JS, Mathis ET, et al. 2003. Modeling interindividual variation in physiological factors used in PBPK models for humans. Crit Rev Toxicol 33:469-503.
37. Ramos L, Hernandez LM, Gonzalez MJ. 1997. Variation of PCB congener levels during lactation period and relationship to their molecular structure. Arch Environ Contam Toxicol 33:97-103.
38. R Foundation for Statistical Computing. 2008. The R Project for Statistical Computing. Available: http://www.r-project.org/ [accessed 30 April 2008].
39. Rusiecki JA, Matthews A, Sturgeon S, Sinha R, Pellizzari E, Zheng T, et al. 2005. A correlation study of organochlorine levels in serum, breast adipose tissue, and gluteal adipose tissue among breast cancer cases in India. Cancer Epidemiol Biomarkers 14(5):1113-1124.
40. Sakai K, Okuyama H, Yura J, Takeyama H, Shinagawa N, Tsuruga N, et al. 1992. Composition and turnover of phospholipids and neutral lipids in human breast cancer and reference tissues. Carcinogenesis 13:579-584.
41. Schecter A, Kassis I, Papke O. 1998. Partitioning of dioxins, dibenzofurans, and coplanar PCBS in blood, milk, adipose tissue, placenta and cord blood from five American women. Chemosphere 37:1817-1823.
42. Seegal RF, Brosch KO, Okoniewski RJ. 1997. Effects of in utero and lactational exposure of the laboratory rat to 2,4,2′,4′- and 3,4,3′,4′-tetrachlorobiphenyl on dopamine function. Toxicol Appl Pharmacol 146:95-103.
43. Sohn MD, McKone TE, Blancato JN. 2004. Reconstructing population exposures from dose biomarkers: inhalation of trichloroethylene (TCE) as a case study. J Expo Anal Environ Epidemiol 14:204-213.
44. Suzuki G, Nakano M, Nakano S. 2005. Distribution of PCDDs/PCDFs and Co-PCBs in human maternal blood, cord blood, placenta, milk, and adipose tissue: dioxins showing high toxic equivalency factor accumulate in the placenta. Biosci Biotechnol Biochem 69:1836-1847.
45. Tilson HA, Jacobson JL, Rogan WJ. 1990. Polychlorinated biphenyls and the developing nervous system: cross-species comparisons. Neurotoxicol Teratol 12:239-248.
46. Vartiainen T, Saarikoski S, Jaakkola JJ, Tuomisto J. 1997. PCDD, PCDF, and PCB concentrations in human milk from two areas in Finland. Chemosphere 34:2571-2583.
47. Wittsiepe J, Fürst P, Schrey P, Lemm F, Kraft M, Eberwein G, et al. 2007. PCDD/F and dioxin-like PCB in human blood and milk from German mothers. Chemosphere 67:S286-S294.